Introduction:
Burning mouth syndrome (BMS) is a chronic pain disorder characterized by burning, stinging, and/or itching of the oral cavity in the absence [1] [2] . Burning sensation usually felt in the normal oral mucosa, especially on the tongue, which affects other mucosal surfaces, including the lips, buccal mucosa and the floor of the mouth 3 .The tongue is found to be the most common location for burning sensation in the oral cavity. BMS can be accompanied by Dysgeusia (distortion in sense of taste), Glossodynia (painful tongue), Glossopyrosis (burning tongue) & Xerostomia (dry mouth the symptoms include a burning sensation, occasional pain, taste disturbances. Burning sensation is mostly reported in postmenopausal women 4 . The most commonly affected area is tip of the tongue and also affects the lips, gingiva and palate. The condition is extremely rare in patients under 30 years and never been reported in children and adolescence 5 . The exact etiology of BMS is unknown. Although there is no definitive cause of primary BMS, there are numerous potential
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a study in 2009 in 30 BMS patients and 30 healthy subjects and compared salivary levels of magnesium, zinc and copper among them and reported there were no significant differences between the two groups4. In a study of Cho et al. in 2010, 20 rats were divided to two groups of 10, where one group received a zinc deficient diet and the other group received a standard diet. After 20 weeks, hyperkeratosis and an increase in mitotic activity were observed in the dorsum area of the tongue of rats receiving the Zn-deficient diet. It is not possible to compare the results of the present study with those of other studies from a clinical point of view due to the limited number of studies on BMS serum zinc levels.
Conclusion:
The results of the present study concluded that zinc supplement reduces the symptom in patients with BMS.
Conflict of Interest: None.
burning sensation and '10' indicating the most severe burning sensation experienced by the study subject. Study subject was asked to determine the severity of their burning sensation from 0 to 10. The patients in the case group were treated with zinc sulphate were administered twice daily and the zinc therapy was continued for three months. In the control group placebo were administered two times daily for three months. After three months, burning sensation severity was evaluated and measured. The serum zinc levels were determined and if these levels were not normal, treatment with zinc sulfate capsules continued for another month. After this period, the subjects were evaluated again and burning sensation severity was determined. After the study, the control group patients also received zinc replacement therapy. Data were analyzed with the SPSS software. The t-test was used to evaluate the means of burning sensation scores and serum zinc levels of the subjects.
Results:
In the present study, 70 patients with BMS, who had zinc deficiency, were evaluated, with 35 subjects in the case and 35 in the control groups. In the case group, there were 32 females and 3 males; in the control group, there were 30 females and 5 males. The mean age of the subjects were 43 ± 5.02 and 45.6 ± 7 years in the case and control groups, respectively, with no statistically significant differences between the two groups. The mean durations of BMS were 2±0.50 and 3.1±.54 years in the case and control groups, respectively, with no statistically significant differences between the two groups . Before intervention there was no difference in sensation severity and serum zinc level between the groups. At the end of the study there was a significant difference in sensation severity and serum zinc level between the two groups.
Table-I: Severities of Burning Sensation and Serum Zinc
Levels Before and After Treatment (n=30).
Discussion:
The results of this study showed that zinc supplementation lessen the severity of burning sensation in patients with BMS. Although the short term follow up studies show potential symptomatic improvement with treatment in patients with BMS, the long-term outcomes for BMS remain unclear. There is an important role of Zinc in the growth and development of the immune system and the neurologic functions. Zinc deficiency also affect the immune system and the repair processes of the mucosa and may cause BMS. Another study conducted by Maragou P et al showed lower serum levels of zinc in patients with BMS compared to healthy subjects 13 
p-value
Burning sensation before the intervention 5.6 ± 1.3 4.9 ± 1.1 0.05
Burning sensation after the intervention 1.4 ± 0.9 4.9 ± 0.69 0.001 Serum zinc level before the intervention, g/dl 60 ± 10.5 62 ± 8.05 0.4
Serum zinc level after the intervention, g/dl 83 ± 0.92 65 ± 2.38 0.008 t-test was used to evaluate the means of burning sensation scores and serum zinc levels of the subjects
